Hinchey Classification for Acute Diverticulitis

The Hinchey classification is a four-stage system that grades the severity of complicated diverticulitis based on how far infection and perforation have spread beyond the colon wall. Published in 1978, it remains the most widely used framework in international surgical literature for deciding how aggressively to treat a perforated diverticulum, ranging from a small contained abscess at Stage I to widespread fecal contamination of the abdomen at Stage IV.¹ The classification matters because each stage carries very different survival odds and calls for very different treatment, from outpatient antibiotics at the mild end to emergency surgery at the severe end.

The Four Original Stages

The original Hinchey system was designed to be applied during open surgery, when the surgeon could directly see how far infection had spread. The stages move from local to diffuse:

Stage I: A small abscess confined to the tissue immediately around the inflamed diverticulum (pericolic abscess).
Stage II: A larger abscess that has walled itself off in the pelvis or elsewhere in the abdomen, typically farther from the colon than a Stage I collection.
Stage III: The abscess has ruptured and pus has spread freely across the abdominal cavity (purulent peritonitis), but without gross fecal contamination.
Stage IV: The perforation has allowed intestinal contents to spill freely, producing fecal peritonitis across the abdomen.

The jump from Stage II to Stage III is the critical dividing line. Below it, infection is still somewhat contained and can often be managed without emergency surgery. Above it, the abdomen is contaminated and the patient almost always needs an operation. A population-level study found that the 100-day relative survival after a first hospital admission was about 97% for uncomplicated disease, roughly 79% when an abscess was present, around 84% for purulent peritonitis, and just 44% for fecal peritonitis. Fecal peritonitis carried an adjusted hazard ratio of about 10.5 compared to uncomplicated disease.²

Why the Original System Got Modified

The original Hinchey stages were meant to describe what a surgeon saw with their own eyes during an open operation. That worked well in the late 1970s, when most complicated diverticulitis went straight to the operating room. But as CT scanning became routine and many patients began being treated without surgery, the system developed a blind spot: it had no way to describe the milder end of the disease spectrum that surgeons were now managing conservatively.

A widely adopted modification, proposed by Kaiser and colleagues in 2005, added substages to fill this gap. It introduced a Stage 0 for clinically mild diverticulitis and split the original Stage I into Stage Ia (limited inflammation around the colon without a true abscess) and Stage Ib (a small abscess has formed). This broadened the classification so it could cover not just perforated disease but also the milder presentations that make up the majority of diverticulitis cases seen in the emergency department.³ Other modified versions exist, but the Kaiser modification is the one most commonly referenced in modern treatment guidelines.

How Well Does CT Predict the Actual Stage

Because most patients now get a CT scan before anyone decides on treatment, a natural question is how accurately the scan maps onto what a surgeon would actually find. The answer is mixed, and it depends on the stage.

One study that compared preoperative CT findings against what surgeons found during surgery reported that only about two-thirds of patients were correctly staged by CT. The positive predictive value varied between about 45% and 89% depending on the stage. The most worrying gap was at Stage III: roughly 42% of patients who turned out to have purulent peritonitis at surgery had been read as Stage I or II on CT. On the more reassuring side, when CT suggested Stage III or IV disease (large amounts of free air plus diffuse fluid), the positive predictive value for needing surgery was 94%.⁴ In practical terms, CT is good at telling you when a patient definitely needs an operation, but less reliable at reassuring you that a patient definitely does not.

A separate study using a different classification system (the Classification of Diverticular Disease, or CDD) reported much higher CT accuracy of about 94% with excellent agreement between radiologists.⁵ The discrepancy likely reflects that the CDD system was designed around imaging findings from the start, while the original Hinchey system was designed around surgical findings and then retroactively applied to CT. When radiologists use the modified Hinchey classification, inter-observer agreement is described as substantial, with a median kappa of 0.72.⁶

The understaging problem has real consequences. One study found that in cases classified as a phlegmonous (inflammatory) type on CT, the preoperative scan correlated with intraoperative findings only about 52% of the time, with overstaging in roughly a third of cases and understaging in about 12%.⁷ Surgeons are aware of this gap and often factor in the clinical picture, blood work, and how sick the patient looks alongside the CT report.

Treatment at Each Stage

The Hinchey stage is the single biggest driver of treatment decisions, though patient fitness, age, and immune status all modify the plan.

Stage Ia and Mild Disease

Patients with limited inflammation and no abscess (modified Hinchey Ia) can often be managed without hospital admission. A meta-analysis found that observation-only treatment is feasible and safe in clinically stable patients at this stage, and that outpatient management produces outcomes comparable to inpatient care, with shorter hospital stays.⁸ Even when CT shows small amounts of pericolic air (which sounds alarming), conservative treatment without antibiotics may be reasonable in selected patients.⁹ This shift toward less aggressive treatment for mild disease is one of the bigger changes in diverticulitis management over the past decade.

Stage Ib and II

When an abscess forms, the traditional approach has been CT-guided percutaneous drainage combined with antibiotics. One study found that drainage successfully controlled the situation in about two-thirds of Hinchey II patients, and about 35% of those drained patients later had a safe elective sigmoid resection with primary anastomosis rather than an emergency operation.¹⁰ The key takeaway from that research was that emergency surgery for Stage II diverticulitis carries a high mortality rate and should be avoided when possible.

Interestingly, one case-control study found that antibiotics alone performed comparably to percutaneous drainage in Stage II patients, particularly when the abscess was in a location that made drainage technically difficult or risky.¹¹ A larger study confirmed that roughly 78% of patients with Hinchey Ib and II abscesses were successfully managed conservatively overall, with only 22% needing surgery during the same admission.¹²

Stage III

Purulent peritonitis has traditionally required resection of the affected colon, usually as a Hartmann’s procedure (removing the diseased segment, closing the rectal stump, and creating a colostomy). In recent years, a less invasive alternative has been studied: laparoscopic lavage, where the surgeon washes out the contaminated abdomen with saline without removing any bowel. A meta-analysis found that laparoscopic lavage had a lower reoperation rate within the first 12 months compared to colon resection, with comparable overall complication and death rates, and was less costly than Hartmann’s procedure.¹³ However, this approach works only for a carefully selected group of Stage III patients and is not suitable for everyone with purulent peritonitis.¹⁴

Stage IV

Fecal peritonitis almost always requires emergency surgery with bowel resection. The debate at this stage is not whether to operate but how: Hartmann’s procedure (with a colostomy) or primary resection with anastomosis (reconnecting the bowel immediately, sometimes with a temporary protective stoma). A large meta-analysis covering over 3,500 patients found that mortality in the primary anastomosis group was lower than in the Hartmann’s group across observational studies. However, when looking at randomized controlled trials alone, the mortality difference was not statistically significant.¹⁵ In practice, Hartmann’s procedure tends to be chosen for older, sicker patients: one multicenter study found that patients who received a Hartmann’s were on average about 75 years old versus 61 for those who got a primary anastomosis, and Stage IV disease was far more common in the Hartmann’s group.¹⁶

The Colostomy Reversal Problem

One of the most significant downstream consequences of Hinchey staging is whether a patient ends up with a permanent colostomy. When a Hartmann’s procedure is performed for Stage III or IV disease, the colostomy is intended to be temporary, but reversal rates are sobering. Estimates range from only 25% to 71% of patients actually having their colostomy reversed, despite the substantial negative impact a permanent stoma has on quality of life.¹⁷ This is one of the strongest arguments favoring primary anastomosis when it is technically feasible: meta-analyses consistently show that both the initial stoma rate and the rate of permanent stoma are lower in patients who get a primary anastomosis, and stoma reversal surgery carries its own complications.¹⁸

Blood Markers and Hinchey Stage

Clinicians often want to gauge disease severity before the CT results come back, and standard blood tests offer some guidance. White blood cell counts and C-reactive protein (CRP) levels both rise with increasing Hinchey stage, with the most pronounced jumps occurring at Stage IV.¹⁹ Among the common markers, CRP appears to be the most useful single predictor of severity. One study identified a CRP cutoff of 173 mg/L for predicting disease worse than Hinchey Ib, with both sensitivity and specificity around 91%.²⁰

Newer research suggests that procalcitonin may outperform CRP for distinguishing severe from mild disease. One retrospective analysis found procalcitonin had a slightly higher predictive accuracy than CRP, and combining biomarkers with specific CT findings improved diagnostic accuracy further.²¹ In practice, a very high CRP in a patient with diverticulitis is a red flag that the disease may be more advanced than the CT suggests, which is useful given CT’s known tendency to understage some cases.

Recurrence After Conservative Treatment

Patients who survive an episode of complicated diverticulitis without surgery often wonder whether it will come back. The answer depends on what the initial episode looked like. For right-sided diverticulitis managed without surgery, a meta-analysis found a pooled recurrence rate of about 12% over roughly three years of follow-up, and about 10% of those who recurred needed emergency surgery.²²

For patients with Hinchey I and II abscesses managed conservatively (with antibiotics or drainage rather than surgery), a long-term study with a median follow-up of over nine years found the overall recurrence rate was 20%. The pattern was striking: patients initially treated with antibiotics alone had a 30% recurrence rate, those treated with drainage plus antibiotics had 27%, and those who had surgery during the initial episode had only 5%. Most recurrences happened within the first few months and were themselves managed conservatively.²³ These numbers inform the ongoing debate about whether patients who recover from a Hinchey I or II abscess should have elective surgery to prevent recurrence, or whether watchful waiting is acceptable given that most recurrences are manageable.

Immunocompromised Patients Present Differently

Patients on immunosuppressive medications or with conditions that weaken the immune system tend to present with more advanced disease. An international registry study found that immunocompromised patients had higher Hinchey grades at presentation compared to patients with normal immune function.²⁴ This likely reflects both a blunted ability to contain infection and a tendency for symptoms to be masked, delaying diagnosis.

The treatment implications are practical. A 12-year management experience found that immunosuppressed patients with Hinchey Ib or II abscesses were significantly more likely to end up needing surgery: 56% underwent an operation compared to 24% of immunocompetent patients with the same stage. For uncomplicated diverticulitis, though, the surgery rate was essentially the same regardless of immune status.²⁵ The takeaway is that the same Hinchey stage can mean different things in different patients. An abscess that would be safely managed with drainage and antibiotics in a healthy person may need surgical attention in someone on immunosuppressive therapy.

Competing Classification Systems

The Hinchey system is not the only game in town. The AAST (American Association for the Surgery of Trauma) grading system and the WSES (World Society of Emergency Surgery) classification are both used, particularly in trauma and emergency surgery settings. A multicenter comparative study tested all three systems head-to-head for their ability to predict outcomes like the need for intervention, major complications, and death. The AAST system was slightly better than the modified Hinchey at predicting who would need an intervention, while the modified Hinchey was slightly better than the WSES system at predicting major complications. For predicting morbidity, reinterventions, and mortality, the three systems performed comparably.²⁶

The modified Hinchey classification persists partly because of inertia and familiarity, and partly because the surgical literature of the past four decades is built around it. Any surgeon trained in colorectal surgery will immediately understand what “Hinchey III” means. The newer systems have theoretical advantages, particularly in incorporating imaging findings more systematically, but none has demonstrated enough superiority to displace Hinchey in everyday clinical use. For patients, the practical difference between systems is minimal. What matters is that the treating team accurately assesses how far infection has spread and tailors treatment accordingly, regardless of which numbering system they use to communicate that assessment.